ADIPOQ and polycystic ovary syndrome: Adiponectin’s negative correlation with BMI (r=-0.513, p=0.009), visceral adiposity index (r=-0.515, p=0.010), and HOMA-IR (r=-0.474, p=0.018) further supports its protective role against metabolic derangements in PCOS.